• Mashup Score: 0

    Acquired haemophilia A is a rare disorder that affects older adults with no previous bleeding history who develop life-threatening bleeding, accompanied by a prolonged activated partial thromboplastin time that fails to correct in a 1:1 mix and caused by a specific autoantibody to factor VIII.1,2 The aim of acquired haemophilia treatment is two-fold: to stop the bleeding, and to eradicate the inhibitor. To date, standard treatment includes haemostatic bypassing agents to prevent bleeding and immunosuppressives to eradicate the inhibitor, which is 90% effective.

    Tweet Tweets with this article
    • "The key message to take from this study is that early rapid emicizumab loading is safe and effective alone, without immunosuppression, in preventing bleeding in acquired #haemophilia A" #hemophilia #bleedingdisorders Linked comment by @ragnmv https://t.co/M0DfipV6bo

  • Mashup Score: 0

    Haemophilia is a bleeding disorder that predisposes individuals affected, primarily males, to bleeding diathesis and spontaneous bleeding into joints, soft tissues, and muscles in varying severities. In the Philippines, there are approximately 1604 patients diagnosed with haemophilia according to the World Federation of Hemophilia 2020 report. However, the real prevalence of disease might be at…

    Tweet Tweets with this article
    • "The Philippines Universal Health Care Act introduced in 2019... along with the pending legislation and efforts to increase insurance coverage for #haemophilia, can have a transformative effect for patients" Global #Haematology - #hemophilia care in🇵🇭 https://t.co/3Zxs7fAaTa https://t.co/1WOlyHL1Zz